Skip to content
Other

Gain (Loss) on Sale of Assets and Asset Impairment Charges

Year-over-year, this metric declined by 100.0%, from -$1M to -$2M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ2 2022
Last reportedQ1 2026Apr 29, 2026
Metric ID: other_gain_loss_on_sales_of_assets_and_asset_impairment_charges

Historical Data

12 periods
 Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$0-$22M-$1M-$4M-$1M-$7M-$6M-$1M-$1M-$5M$0-$2M
QoQ Change+95.5%-300.0%+75.0%-600.0%+14.3%+83.3%+0.0%-400.0%+100.0%
YoY Change+95.5%-600.0%-50.0%+0.0%+85.7%+16.7%+100.0%-100.0%
Range-$22M$0
Avg YoY Growth-56.5%
Median YoY Growth+8.3%

Gain (Loss) on Sale of Assets and Asset Impairment Charges at Other Companies

Frequently Asked Questions

What is GE HealthCare Technologies's gain (loss) on sale of assets and asset impairment charges?
GE HealthCare Technologies (GEHC) reported gain (loss) on sale of assets and asset impairment charges of -$2M in Q1 2026.
How has GE HealthCare Technologies's gain (loss) on sale of assets and asset impairment charges changed year-over-year?
GE HealthCare Technologies's gain (loss) on sale of assets and asset impairment charges decreased by 100.0% year-over-year, from -$1M to -$2M.